ZENTALIS PHARMACEUTICALS INC
ZNTL·98943L107·US·Common Stock·Healthcare - Biotechnology-Activist
ZNTL (ZENTALIS PHARMACEUTICALS INC) is held by 60 institutional investors as of Q1 2026. Largest holders: TWO SIGMA INVESTMENTS, LP ($6.9M), VANGUARD CAPITAL MANAGEMENT LLC ($5.4M), RENAISSANCE TECHNOLOGIES LLC ($4.5M). Net institutional sentiment: Mixed.
60
Holders
Avg rating(13 Elite)
$57.8M
Total Value
62% (63)
Fund Consensus
36 buying - 22 selling
Who's Trading
ActivistSMSquadron Master Fund LP5.1%Mar 3, 2026
ActivistWWWalters William T19.7%Jan 5, 2026
ActivistMAMatrix Capital Management Company, LP0.0%Jan 2, 2026
InsiderWGWALTERS GROUPBuy $7.8MDec 31, 2025
Activist5O5AM Opportunities II (GP), LLC5.2%Dec 30, 2025
InsiderMLMatrix Capital Management Company, LPSell $10.0MDec 15, 2025
InsiderMDMyers Scott DunsethBuy $29KApr 30, 2025
13F: Insider & Congress:
Showing 1-20 of 63
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer